FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 62 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,129 | -99.9% | 341,972 | -16.7% | 0.11% | -9.8% |
Q1 2023 | $1,170,535 | -60.9% | 410,714 | 0.0% | 0.12% | -66.8% |
Q4 2022 | $2,989,998 | -10.0% | 410,714 | 0.0% | 0.37% | -10.2% |
Q3 2022 | $3,323,000 | +65.2% | 410,714 | 0.0% | 0.41% | +77.3% |
Q2 2022 | $2,012,000 | -79.3% | 410,714 | 0.0% | 0.23% | -76.2% |
Q1 2022 | $9,713,000 | +33.7% | 410,714 | 0.0% | 0.98% | +43.7% |
Q4 2021 | $7,266,000 | -37.3% | 410,714 | 0.0% | 0.68% | +0.4% |
Q3 2021 | $11,586,000 | +169.2% | 410,714 | 0.0% | 0.68% | +173.8% |
Q2 2021 | $4,304,000 | -11.0% | 410,714 | 0.0% | 0.25% | -8.1% |
Q1 2021 | $4,838,000 | +0.6% | 410,714 | 0.0% | 0.27% | +3.4% |
Q4 2020 | $4,809,000 | +47.7% | 410,714 | 0.0% | 0.26% | +45.8% |
Q3 2020 | $3,257,000 | -56.6% | 410,714 | 0.0% | 0.18% | -72.1% |
Q2 2020 | $7,512,000 | +53.2% | 410,714 | 0.0% | 0.64% | -16.4% |
Q1 2020 | $4,904,000 | -28.2% | 410,714 | 0.0% | 0.77% | +6.1% |
Q4 2019 | $6,834,000 | +150.6% | 410,714 | 0.0% | 0.72% | +184.6% |
Q3 2019 | $2,727,000 | – | 410,714 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |